PCSA Processa Pharmaceuticals
- 2.0200
- -0.1600-7.34%
- 2.0200
- 0.00000.00%
Processa Pharmaceuticals News
Express News | HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $8 Price Target
Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Oculis Holding (OCS)
Processa Pharmaceuticals | 10-Q: Quarterly report
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company focused on developing the next gen
Express News | Processa Pharmaceuticals Names DR. Steven Cha Senior Vice President of Clinical Research
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
HTZ, CYCC and WORX Among Pre-market Losers
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its first quarter.Google parent Alphabet said its first-quarter re
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. The company's market cap stands at $245.2 million. Cryo-Cell International (AMEX:CCEL) shares i
Top Premarket Decliners
SCWorx (WORX) shares retreated 17% Friday premarket, reversing gains from the previous session. Processa Pharmaceuticals (PCSA) shares fell more than 15%, paring Thursday's rally. Boyd Gaming (BYD) sh
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
Top Midday Gainers
H.C. Wainwright started Processa Pharmaceuticals (PCSA) with a buy rating and an $8 price target. Shares soared 41.4%, as intraday trading volume shot to more than 62.6 million from a daily average of
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by around 250 points on Thursday.The Dow traded down 1.55% to 37,864.79 while the NASDAQ fell 1.60% to 15,460.95. The
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
Express News | Processa Pharmaceuticals Shares Are Trading Higher After HC Wainwright & Co Initiated Coverage on the Stock With a Buy Rating and Announced an $8 Price Target
Processa Pharmaceuticals Initiated at Buy by HC Wainwright & Co.
Processa Pharmaceuticals Initiated at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Initiates Coverage On Processa Pharma With Buy Rating, Announces Price Target of $8
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. The company's market cap stands at $40.7 million. Allarity Therapeutics (NASDAQ:ALLR
Express News | Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the Ngc-Cap Phase 1B Trial
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) presented two abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2024, including new Phase 1b data on its Next Generation Capecitabine (NGC-Cap) product.
Analysis
Price Target
No Data
